Powerful cholesterol drug cuts heart attack risk by 31%

Mass General Brigham researchers report that the cholesterol-lowering drug evolocumab can significantly reduce the risk of a first major cardiovascular event in people with diabetes who are considered high risk

T cells’ capability to fully prevent acute viral infections opens new avenues for vaccine development

Scientists from Duke-NUS Medical School and the Singapore General Hospital have discovered that T cells — white blood cells that can destroy harmful pathogens — can completely prevent viral infection,

Addiction affects your brain as well as your body – that’s why detoxing is just the first stage of recovery

Addiction is one of the most common and consequential chronic medical conditions in the United States. Nationwide, more than 46 million people met the criteria for a substance abuse disorder